1. Academic Validation
  2. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells

GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells

  • Immunity. 2003 Apr;18(4):535-47. doi: 10.1016/s1074-7613(03)00084-0.
Niroshana Anandasabapathy 1 Gregory S Ford Debra Bloom Claire Holness Violette Paragas Christine Seroogy Heidi Skrenta Marie Hollenhorst C Garrison Fathman Luis Soares
Affiliations

Affiliation

  • 1 Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, CA 94305, USA.
Abstract

T cell anergy may serve to limit autoreactive T cell responses. We examined early changes in gene expression after antigen-TCR signaling in the presence (activation) or absence (anergy) of B7 costimulation. Induced expression of GRAIL (gene related to anergy in lymphocytes) was observed in anergic CD4(+) T cells. GRAIL is a type I transmembrane protein that localizes to the endocytic pathway and bears homology to RING zinc-finger proteins. Ubiquitination studies in vitro support GRAIL function as an E3 ubiquitin Ligase. Expression of GRAIL in retrovirally transduced T cell hybridomas dramatically limits activation-induced IL-2 and IL-4 production. Additional studies suggest that GRAIL E3 ubiquitin Ligase activity and intact endocytic trafficking are critical for cytokine transcriptional regulation. Expression of GRAIL after an anergizing stimulus may result in ubiquitin-mediated regulation of proteins essential for mitogenic cytokine expression, thus positioning GRAIL as a key player in the induction of the anergic phenotype.

Figures